Eira Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.19 M
- Satisfied Charges ₹ 0.50 M
- Revenue Growth 33.65%
- Profit Growth 101.21%
- Ebitda 112.38%
- Net Worth 1.87%
- Total Assets 81.69%
About Eira Life Sciences
Eira Life Sciences Private Limited (ELSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 May 2015 (Nine years and eight months 16 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.19 M. The company has closed loans amounting to ₹0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ajithkumar Gangadharan and Nimy Prasad serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2015PTC100663
-
Company No.
100663
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 May 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Eira Life Sciences Private Limited offer?
Eira Life Sciences Private Limited offers a wide range of products and services, including Osteoporosis Medications, Forteo Injections, Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Eira Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajithkumar Gangadharan
|
Director | 26-May-2015 | Current |
|
Nimy Prasad
|
Director | 15-May-2018 | Current |
Financial Performance of Eira Life Sciences.
Eira Life Sciences Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 33.65% increase. The company also saw a substantial improvement in profitability, with a 101.21% increase in profit. The company's net worth moved up by a moderate rise of 1.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eira Life Sciences?
In 2019, Eira Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.19 M
₹0.50 M
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2020 | Others | ₹0.19 M | Open |
| 16 Jun 2018 | Others | ₹1.00 M | Open |
| 10 Feb 2016 | Oriental Bank Of Commerce | ₹0.50 M | Satisfied |
How Many Employees Work at Eira Life Sciences?
Unlock and access historical data on people associated with Eira Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eira Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eira Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
